Has Iyad Azzam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $59,613 in general payments to Iyad Azzam, MD across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Iyad Azzam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Iyad Azzam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Iyad Azzam, MD

Interventional Cardiology · Milwaukee, WINPI 1811216229

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 63.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $31,846 and has fallen 61.4% since, to $12,303 in 2024. Among interventional cardiology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,613in general payments, 2019–2025

Across 158 payments — averaging $377.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$38K
Abiomed$12K
Teleflex LLC$4K
Medtronic$2K
Heartflow, Inc.$2K
Abbott$747
plus $1K from 7 others

What the payments were for

Consulting fees$17,70030%
Speaking & faculty fees$22,80038%
Travel & lodging$11,14119%
Food & beverage$7,97213%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	78	$37,775
Abiomed	25	$12,067
Teleflex LLC	10	$4,012
Medtronic(2 entities)	14	$2,235
Heartflow, Inc.	7	$1,662
Abbott	9	$747
Cardiovascular Systems Inc.	8	$682
Endologix LLC	1	$143
Philips North America LLC	1	$108
Asahi Intecc USA, Inc.	1	$94
Teleflex Medical Incorporated	2	$39
Edwards Lifesciences	1	$36
Cardiva Medical, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$11,328
WOLVERINE CORONARY CUTTING BALLOON$5,000
MANTA$3,853
Resolute$1,700
FFRct$1,582
GENERAL VASCULAR ACCESS$1,500
GENERAL - THERAPIES$1,029
Peripheral Orbital Atherectomy System$616
Rotablator Rotational Atherectomy System Console Kit$551
OPTICROSS$381
AVVIGO Guidance System$335
Xience V coronary stent system$147
Ovation iX Iliac Stent Graft$143
CHOICE$141
GENERAL ATHERECTOMY$134
GENERAL - STENTS$127
COROFLOW$126
SYNERGY$123
Xience Sierra Coronary Stent$119
COMET$116

How this compares

$59,613 in reported general payments places this provider in the 90th percentile of 118 interventional cardiology providers in Wisconsin.

See all interventional cardiology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$27,525

Medicare patients

Services billed

171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	91	$1,019
Bumetanide	14	$235
Isosorbide Mononitrate ErIsosorbide Mononitrate	18	$228
Metoprolol Succinate	12	$185
Pantoprazole Sodium	23	$127

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Milwaukee

Michael SalingerMilwaukee$216K
Tanvir BajwaMilwaukee$106K
Suhail AllaqabandMilwaukee$88K
Saif AnwaruddinMilwaukee$80K
Montoya TaylorMilwaukee$48K
Mina IskanderMilwaukee$41K
Anna LarosaMilwaukee$38K
Louie KostopoulosMilwaukee$26K
Daniel JohnsrudMilwaukee$25K
Sasanka JayasuriyaMilwaukee$15K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →